| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |